Revenue, last quarter
$1.8M
+63.8% vs same quarter last year
Net income
$157K
−99.9% vs same quarter last year
EPS, diluted
$0.04
−99.9% vs same quarter last year
Operating cash flow
−$12.2M
−563% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $6.4M | $183.5M |
| FY24 | $29.6M | −$47.6M |
| FY23 | $46.8M | −$284.2M |
| FY22 | $140.7M | −$293.7M |
| FY21 | $235.3M | −$290M |
| FY20 | $176.3M | −$189.3M |
| FY19 | $256.6M | −$77M |
| FY18 | $213M | −$86.4M |
| FY17 | $131M | −$120.9M |
| FY16 | $183.2M | −$58.1M |
| FY15 | $180.8M | −$85.8M |
| FY14 | $137.6M | −$59.5M |
| FY13 | $102.2M | −$14.9M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 91.4% | −712.7% | 2848.6% |
| FY24 | 47.5% | −507.8% | −160.6% |
| FY23 | 91.5% | −689.5% | −607.3% |
| FY22 | 85.6% | −213.9% | −208.7% |
| FY21 | 94.5% | −122.6% | −123.3% |
| FY20 | 95% | −108.8% | −107.4% |
| FY19 | 99.6% | −34.8% | −30% |
| FY18 | - | −40.7% | −40.6% |
| FY17 | - | −89.5% | −92.3% |
| FY16 | - | −27.3% | −31.7% |
| FY15 | - | −42.9% | −47.4% |
| FY14 | - | −36.4% | −43.2% |
| FY13 | - | −7.8% | −14.6% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$4.8M |
| FY24 | −$138.3M |
| FY23 | −$317.5M |
| FY22 | −$149.7M |
| FY21 | −$87.4M |
| FY20 | $77.6M |
| FY19 | −$84.5M |
| FY18 | −$84.2M |
| FY17 | −$75M |
| FY16 | $5.9M |
| FY15 | −$20.5M |
| FY14 | $14.3M |
| FY13 | $19.1M |
| FY12 | - |
- Kyntra Bio
- Healthcare median
Show the numbers
| Year | Kyntra Bio | Healthcare median |
|---|---|---|
| FY25 | 2848.6% | −30.6% |
| FY24 | −160.6% | −47% |
| FY23 | −607.3% | −58% |
| FY22 | −208.7% | −80.4% |
| FY21 | −123.3% | −71.9% |
| FY20 | −107.4% | −62.2% |
| FY19 | −30% | −46.3% |
| FY18 | −40.6% | −49.6% |
| FY17 | −92.3% | −45.9% |
| FY16 | −31.7% | −36% |
| FY15 | −47.4% | −38.4% |
| FY14 | −43.2% | −35.5% |
| FY13 | −14.6% | −37.1% |
| FY12 | - | −29.1% |